Project Details
| Status | Active |
|---|---|
| Effective start/end date | 12/9/19 → 8/31/50 |
Funding
- Children’s Hospital of Philadelphia
- Eisai Medical Research Inc.
GOG ADVL1722 - A Phase 2, multicenter, open-label study to assess safety and preliminary activity of eribulin mesylate in pediatric subjects with relapsed/refractory rhabdomyosarcoma (RMS), nonrhabdomyosarcoma soft tissue sarcoma (NRSTS) and Ewing sarcoma
- Walterhouse, David O (PD/PI)
Project: Research project